KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Elevance Health (ELV) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Elevance Health (ELV) over the last 17 years, with Q4 2025 value amounting to 0.99%.

  • Elevance Health's EBIT Margin fell 1700.0% to 0.99% in Q4 2025 from the same period last year, while for Dec 2025 it was 1.1%, marking a year-over-year decrease of 600.0%. This contributed to the annual value of 1.1% for FY2025, which is 600.0% down from last year.
  • Per Elevance Health's latest filing, its EBIT Margin stood at 0.99% for Q4 2025, which was down 1700.0% from 1.23% recorded in Q3 2025.
  • Elevance Health's 5-year EBIT Margin high stood at 1.24% for Q4 2023, and its period low was 0.9% during Q1 2021.
  • Moreover, its 5-year median value for EBIT Margin was 0.99% (2022), whereas its average is 1.05%.
  • In the last 5 years, Elevance Health's EBIT Margin soared by 9900bps in 2021 and then plummeted by -2000bps in 2022.
  • Elevance Health's EBIT Margin (Quarter) stood at 0.96% in 2021, then decreased by -3bps to 0.93% in 2022, then surged by 33bps to 1.24% in 2023, then fell by -7bps to 1.16% in 2024, then decreased by -15bps to 0.99% in 2025.
  • Its EBIT Margin was 0.99% in Q4 2025, compared to 1.23% in Q3 2025 and 0.98% in Q2 2025.